Unity Health Toronto: Diabetes Mellitus, Type 2 trials
The registry lists 17 Diabetes Mellitus, Type 2 studies with Unity Health Toronto as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 6Phase 3 1Phase 4 3No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance DialysisRecruitingNCT07017270Phase 4
- Effect of a Healthy Food Voucher on Blood Glucose Control in People With Type 2 Diabetes or PrediabetesRecruitingNCT05776420Phase 3
- Konjac-Mannan Improves Glycemia and Other Risk Factors for CHD in T2DMCompletedNCT03741660Phase 2
- Effect of Viscous Soluble Fibres on Body WeightStatus unknownNCT03257449
- Effects of Empagliflozin on Cardiac Structure in Patients With Type 2 DiabetesStatus unknownNCT02998970Phase 4
- Effect of Ginseng in Type 2 DiabetesCompletedNCT02923453Phase 2
- ALA on Glycemic Control in T2DM ParticipantsStatus unknownNCT02701894
- The Effect of Viscous Fiber on Glycemic Control in Individuals With DiabetesCompletedNCT02629263
- Fibre Grain Herb Trial in Type 2 DiabetesCompletedNCT02553382Not applicable
- Saxagliptin and Cardiac Structure and FunctionCompletedNCT02481479Phase 4
- Canola-Mediterranean Diet Study in T2DMCompletedNCT02245399Not applicable
- Acute Dose Response of Korean White Ginseng in Metabolic Syndrome or Type 2 DiabetesCompletedNCT01699074Phase 1
- Combined Rg3-enriched Korean Red Ginseng and American Ginseng in the Management of Hypertension in Type 2 DiabetesCompletedNCT01578837Phase 1/2
- Lifestyle Intervention For Effective Diabetes ManagementStatus unknownNCT00813930Not applicable
- Metabolic and Therapeutic Effects of American and Korean Red Ginseng in the Treatment of Type 2 DiabetesStatus unknownNCT00728403Phase 2
- Innovative Strategies For Risk Reduction Following CABGCompletedNCT00462436Phase 2
- Effect of Chia Seeds (Salvia Hispanica L.) on Glucose Control in Patients With Type 2 DiabetesCompletedNCT00362011Phase 2